Diabetic patients treated with metformin during early stages of Alzheimer's disease show a better integral performance: data from ADNI study

We evaluated the effect of the antidiabetic drug metformin on patients enrolled in the ADNI study considering patients with mild cognitive impairment (MCI) due to Alzheimer's disease (AD). Employing data from this observational study, we performed a principal component analysis focusing on the...

Full description

Autores:

Pomilio, Carlos
González Pérez, Nicolás
Calandri, Ismael
Crivelli, Lucía
Allegri, Ricardo
Sevlever, Gustavo
Saravia, Flavia

Tipo de recurso:

Article of investigation

Fecha de publicación:

2022

Institución:

Corporación Universidad de la Costa

Repositorio:

REDICUC - Repositorio CUC

Idioma:

eng

OAI Identifier:

oai:repositorio.cuc.edu.co:11323/10907

Acceso en línea:

https://hdl.handle.net/11323/10907
https://repositorio.cuc.edu.co

Palabra clave:

Alzheimer's disease
Metformin
Type 2 diabetes

Rights

openAccess

License

Atribución-NoComercial-SinDerivadas 4.0 Internacional (CC BY-NC-ND 4.0)